NA previously received 1 bivalent vaccine doseĭose 1: 3–8 weeks after monovalent dose *Ģ doses monovalent Pfizer-BioNTech and 1 dose bivalent Pfizer-BioNTech Vaccine doses should be administered by the intramuscular route.Īt least 8 weeks after last monovalent doseĢ doses monovalent Moderna and 1 dose bivalent Moderna However, for COVID-19 vaccination there are exceptions for children who receive the Pfizer-BioNTech COVID-19 Vaccine and transition from age 4 to 5 years during the 3-dose vaccination series and children who transition from age 5 years to 6 years during the Moderna COVID-19 vaccination series (see Transitioning from a younger to older age group).įor additional guidance on vaccination in specific situations, see Considerations for extended intervals for COVID-19 vaccine doses and COVID-19 vaccination and SARS-CoV-2-infection. In general, CDC recommends that people receive the age-appropriate vaccine product and dosage based on their age on the day of vaccination in accordance with the recommended intervals for that age group ( 1). The monovalent Novavax COVID-19 Vaccine remains authorized for use as a 2-dose primary series and as a booster dose in certain limited situations. People ages 12 years an older who previously received 1 or 2 monovalent Novavax primary series dose(s) are recommended to receive 1 bivalent mRNA vaccine dose.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |